HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arthur Gutierrez-Hartmann Selected Research

Proto-Oncogene Proteins c-ets

8/2020ETS transcription factor ESE-1/Elf3 is an independent prognostic factor of survival in HR+HER2+ breast cancer patients.
11/2013Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.
8/2012Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors.
6/2009The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice.
5/2007ETS transcription factors in endocrine systems.
2/2003The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arthur Gutierrez-Hartmann Research Topics

Disease

9Breast Neoplasms (Breast Cancer)
01/2021 - 02/2003
9Neoplasms (Cancer)
08/2020 - 05/2007
8Carcinogenesis
09/2017 - 02/2003
3Prolactinoma (Prolactinomas)
01/2018 - 11/2011
2Adenoma (Adenomas)
01/2018 - 01/2015
1Melanoma (Melanoma, Malignant)
01/2019
1Skin Neoplasms (Skin Cancer)
01/2019
1Infertility (Sterility)
01/2018
1Hypogonadism (Hypergonadotropic Hypogonadism)
01/2018
1Osteoporosis
01/2018
1Ovarian Neoplasms (Ovarian Cancer)
03/2017
1Thrombocytopenia (Thrombopenia)
05/2015
1Hyperprolactinemia
01/2015
1Neoplasm Metastasis (Metastasis)
11/2013
1Colorectal Neoplasms (Colorectal Cancer)
08/2012
1Anaplastic Thyroid Carcinoma
08/2009
1Thyroid Neoplasms (Thyroid Cancer)
08/2009
1Carcinoma (Carcinomatosis)
06/2009
1Pituitary Neoplasms (Pituitary Adenoma)
12/2002

Drug/Important Bio-Agent (IBA)

6Proto-Oncogene Proteins c-etsIBA
08/2020 - 02/2003
5ProlactinIBA
01/2018 - 12/2002
5Transcription Factors (Transcription Factor)IBA
03/2017 - 02/2003
4Proteins (Proteins, Gene)FDA Link
08/2020 - 06/2004
3Trastuzumab (Herceptin)FDA Link
01/2021 - 12/2017
2Hormones (Hormone)IBA
08/2020 - 05/2007
2Messenger RNA (mRNA)IBA
08/2020 - 09/2017
2Epidermal Growth Factor (EGF)IBA
08/2012 - 12/2002
1human ERBB2 proteinIBA
01/2021
1EpitopesIBA
08/2020
1Estrogen Receptor alphaIBA
08/2020
1Phenobarbital (Luminal)FDA Link
08/2020
1Pharmaceutical PreparationsIBA
01/2019
1Small Interfering RNA (siRNA)IBA
01/2019
1amsonic acid (DAS)IBA
01/2018
1Dopamine Agonists (Dopamine Agonist)IBA
01/2018
1Dopamine (Intropin)FDA LinkGeneric
01/2018
1NucleotidesIBA
05/2015
1MicroRNAs (MicroRNA)IBA
08/2012
1Aspartic Acid (Aspartate)FDA Link
08/2011
1AcidsIBA
08/2011
1Serine (L-Serine)FDA Link
08/2011
1Nuclear Export Signals (Nuclear Export Signal)IBA
06/2011
12- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA
08/2009
1Mitogen-Activated Protein KinasesIBA
08/2009
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2009
1MAP Kinase Kinase 1IBA
08/2009
1villinIBA
06/2009
1Estrogen ReceptorsIBA
06/2004
1Progesterone Receptors (Progesterone Receptor)IBA
06/2004

Therapy/Procedure

2Therapeutics
01/2019 - 11/2013
1Microbubbles
01/2019
1Precision Medicine
01/2019